milliporesigma videos
-
Storing Your Banks With Ease And Confidence
2/17/2023
Discover a biorepository that will fulfill your need of long-term and short-term storage. You can never be too careful with your cell or virus banks. Explore three global sites that will ensure the safety of your bank.
-
The Journey To Safety Through Viral Clearance
12/1/2022
Discover a simple yet powerful solution for getting viral clearance studies done safely, thoroughly, efficiently, and on your timelines. Learn how to free your teams and trust your project.
-
The ICH Q5A Revision, Its New Scope And Guidance
12/1/2022
Learn about the ICH Q5A revision addressing viral safety of biotechnology products derived from cell lines of human or animal origin that was recently published for public comment.
-
ICH Q7 Good Manufacturing Practice Guide For Active Pharmaceutical Ingredients
6/7/2022
The ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients is the most commonly referenced quality guideline in pharmaceutical product and contains five segments. Watch the video to learn more.
-
Combining Expertise With Best-In-Class Technology
10/20/2021
Members of the MilliporeSigma leadership team reflect on the longstanding experience of our BioReliance® viral vector manufacturing facilities. Our legacy experience, alongside our brand new facility and latest industry innovations, ensure we are a preferred partner to pioneer the path to cures.
-
How MilliporeSigma Promotes Quality And Risk Reduction
10/20/2021
Learn how MilliporeSigma’s new facility was built with quality and risk reduction at the top of mind and its experts have the experience to support large-scale programs through commercialization.
-
MilliporeSigma Large Scale Capabilities Tour
10/20/2021
A detailed look at MilliporeSigma’s new BioReliance® viral vector manufacturing facility and how we have employed the latest innovations and quality systems to deliver best-in-class gene therapy services.
-
The Blazar® Platform In A Minute
3/12/2021
The Blazar® Rodent Panel from the BioReliance® portfolio can speed cell line characterization and bulk harvest lot release testing. This degenerate PCR-based method accelerates characterization by reducing timelines by up to 80% and replaces the use of animals.
-
Level Up With Product Characterization
3/12/2021
In the race to bring a new biotherapeutic to market, unexpected obstacles can slow you down or even knock you back a few steps. But with the right information at the right time, and an experienced partner to provide scientific, regulatory, and bioprocessing guidance and support, you can find a smoother, faster path to the finish line.
-
CHO Fed-batch Portfolio: Cellvento® And EX-CELL® Advanced Media And Feeds
3/11/2021
Cellvento® and EX-CELL® Advanced cell culture media supports consistent growth and performance from development to production. Get the enhanced performance, assured regulatory compliance and the security of supply necessary in today’s biopharmaceutical environment.